Antimicrobial Resistance
MRSA and vancomycin-resistant enterococci associated with adverse outcomes
Published in TB and Outbreaks Week, August 10th, 2004
"Two types of cohort studies examining patients infected with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) were contrasted, using different reference groups," investigators in the U.S. report.
"Cases were compared to uninfected patients and patients infected with the corresponding, susceptible organism. VRE and MRSA were associated with adverse outcomes," said K.S. Kaye and coauthors.
"The effect was greater when uninfected control patients were used,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Obesity
Alternate measure of obesity epidemic sensitive to changes in BMI distribution - Pharmaceutical & Drug Development
Protease inhibitor nelfinavir inhibits replication of coronavirus - Yellow Fever
Yellow fever outbreak reported in Imatong, southern Sudan - Air Pollution
Maximum levels of benzene found at traffic stops and gas stations in Mumbai city - Anti-Infectives
Terbinafine and amphotericin B effective against Fusarium infection - Avian Influenza
Bird flu resurfaces in parts of Indonesia, prompts vaccination - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
